MedTrace Logo

Castror Oil for Labor Induction in Women With Previous Cesarean Section

NCT03958981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-12-02

No results posted yet for this study

Summary

Nowadays, more and more women embark on pregnancy with previous Caesarean scar. One in five pregnancies requires induction of labour. The use of non-pharmacological methods (methods without using medication) has been gaining popularity for women who are not good candidates, such as women with previous Caesarean scar, for induction with medications such as prostaglandin. Labour induction with prostaglandin carries a higher risk of uterine rupture and thus it is not routinely offered to women with previous Caesarean delivery in Cairo University Hospital. Non-pharmacological methods of induction of labour appear to be safe in women with previous Caesarean delivery. However, various methods are available and the efficacy among them remain in doubt.

Conditions

  • Induction of Labor

Interventions

DRUG

Castor Oil

The intervention group will be given 60 mL of castor oil in 140 mL of orange juice

DRUG

placebo

the control group will be given a sunflower oil as a placebo with a similar texture to castor oil

Sponsors & Collaborators

  • Mohamed El Sharkawy

    collaborator UNKNOWN

  • Yomna Bayoumi

    collaborator UNKNOWN

  • mohamed hisham gouda

    collaborator UNKNOWN

  • Dina latif

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • Yomna Bayoumi, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2020-05-30
Completion
2020-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03958981 on ClinicalTrials.gov